Education
About Us
Working with TipRanks
Follow Us
Thermo Fisher Scientific (TMO)
NYSE:TMO
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 44.56B | $ 42.88B | $ 42.86B | $ 44.91B | $ 39.21B |
| Gross Profit | $ 16.78B | $ 17.73B | $ 17.19B | $ 19.01B | $ 19.63B |
| Operating Income | $ 8.11B | $ 7.66B | $ 7.45B | $ 8.53B | $ 10.32B |
| EBITDA | $ 10.89B | $ 11.80B | $ 11.20B | $ 11.94B | $ 11.97B |
| Net Income | $ 6.74B | $ 6.33B | $ 6.00B | $ 6.95B | $ 7.72B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 10.11B | $ 5.57B | $ 8.08B | $ 8.52B | $ 4.48B |
| Total Assets | $ 110.34B | $ 97.32B | $ 98.73B | $ 97.15B | $ 95.12B |
| Total Debt | $ 39.38B | $ 32.77B | $ 36.42B | $ 36.07B | $ 36.34B |
| Net Debt | $ 29.53B | $ 28.76B | $ 28.34B | $ 27.54B | $ 31.85B |
| Total Liabilities | $ 56.81B | $ 47.65B | $ 51.88B | $ 53.01B | $ 54.15B |
| Stockholders' Equity | $ 53.41B | $ 49.58B | $ 46.73B | $ 43.98B | $ 40.79B |
| Cash Flow | |||||
| Free Cash Flow | $ 6.29B | $ 7.27B | $ 6.93B | $ 6.91B | $ 7.02B |
| Operating Cash Flow | $ 7.82B | $ 8.67B | $ 8.41B | $ 9.15B | $ 9.54B |
| Investing Cash Flow | $ -4.05B | $ -5.84B | $ -5.14B | $ -2.16B | $ -21.93B |
| Financing Cash Flow | $ 1.80B | $ -6.79B | $ -3.62B | $ -2.81B | $ 6.58B |